The role of mutation accumulation in HIV progression

Proceedings of the Royal Society B: Biological Sciences

Volumn 272, Issue 1574, 2005, Pages 1851-1858

  Galvani, Alison P ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

AIDS HIV; Lymphocytes; Model; Mutation; Progression

Indexed keywords

MUTATION;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL CELL; ARTICLE; B LYMPHOCYTE; CELL VIABILITY; CONTROLLED STUDY; DETERIORATION; DISEASE COURSE; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE FUNCTION TEST; MATHEMATICAL MODEL; MUTATION; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; TURNOVER TIME;

EID: 26244453946     PISSN: 09628452     EISSN: 14712970     Source Type: Journal    
DOI: 10.1098/rspb.2005.3083     Document Type: Article

References (70)

1. Ahr, B., Robert-Hebmann, V., Devaux, C. & Biard-Piechaczyk, M. 2004 Apoptosis of uninfected cells induced by HIV envelope glycoproteins. Retrovirol 1, 12.
2. +T lymphocyte cell death in human immunodeficiency virus infection and AIDS. J. Gen. Virol. 84, 1649-1661.
3. Almeida, A. R., Borghans, J. A. & Freitas, A. A. 2001 T cell homeostasis: thymus regeneration and peripheral T cell restoration with a reduced fraction of competent precursors. J. Exp. Med. 194, 591-599.
4. Bestilny, L. J., Gill, M. J., Mody, C. H. & Riabowol, K. T. 2000 Accelerated replicative senescence of the peripheral immune system induced by HIV infection. AIDS 14, 771-780.
5. Broussard, S. R., Staprans, S. I., White, R., Whitehead, E. M., Feinberg, M. B. & Allan, J. S. 2001 Simian immunodeficiency virus replicates to high levels in naturally infected African green monkeys without inducing immunologic or neurologic disease. J. Virol. 75, 2262-2275.
6. Cairns, J. 2002 Somatic stem cells and the kinetics of mutagenesis and carcinogenesis. Proc. Natl Acad. Sci. USA 99, 10 567-10 570.
7. Cao, H. et al. 2003 Immunogenicity of a recombinant human immunodeficiency virus (HIV)-canarypox vaccine in HIV-seronegative Ugandan volunteers: results of the HIV Network for Prevention Trials 007 vaccine study. J. Infect. Dis. 187, 887-895.
8. Chakrabarti, L. A. et al. 2000 Normal T-cell turnover in sooty mangabeys harboring active simian immunodeficiency virus infection. J. Virol. 74, 1209-1223.
9. + cell numbers and clinical staging. J. Clin. Invest. 84, 1892-1899.
10. Cohen, O. J. & Fauci, A. S. 2001 Current strategies in the treatment of HIV infection. Adv. Intern. Med. 46, 207-246.
11. Consortium, T. G. I. S. 2001 Initial sequencing and analysis of the human genome. Nature 409, 860-921.
12. De Boer, R. J. & Noest, A. J. 1998 T cell renewal rates, telomerase, and telomere length shortening. J. Immunol. 160, 5832-5837.
13. De Boer, R. J., Mohri, H., Ho, D. D. & Perelson, A. S. 2003 Turnover rates of B cells, T cells, and NK cells in simian immunodeficiency virus-infected and uninfected rhesus macaques. J. Immunol. 170, 2479-2487.
14. De Milito, A. 2004 B lymphocyte dysfunctions in HIV infection. HIV Res. 2, 11-21.
15. De Renzo, A. et al. 2002 High prevalence of hepatitis G virus infection in Hodgkin's disease and B-cell lymphoproliferative disorders: absence of correlation with hepatitis C virus infection. Haematologica 87, 714-718.
16. Douek, D. C. et al. 1998 Changes in thymic function with age and during the treatment of HIV infection. Nature 396, 690-695.
17. + cells is mediated by the chemokine receptor CC-CkR5. Nature 381, 667-673.
18. Dragic, T. et al. 2000 A binding pocket for a small molecule inhibitor of HIV-1 entry within the transmembrane helices of CCR5. Proc. Natl Acad. Sci. USA 97, 5639-5644.
19. + cell subset in HIV disease implicate replicative senescence in HIV pathogenesis. AIDS 10, F17-F22.
20. Emini, E. A. et al. 1992 Prevention of HIV-1 infection in chimpanzees by gp120 V3 domain-specific monoclonal antibody. Nature 355, 728-730.
21. Eyre-Walker, A. & Keightley, P. D. 1999 High genomic deleterious mutation rates in hominids. Nature 397, 344-347.
22. Fauci, A. S. 1993 Multifactorial nature of human immunodeficiency virus disease: implications for therapy. Science 262, 1011-1018.
23. Finkel, T. H., Tudor-Williams, G., Banda, N. K., Cotton, M. F., Curiel, T., Monks, C., Baba, T. W., Ruprecht, R. M. & Kupfer, A. 1995 Apoptosis occurs predominantly in bystander cells and not in productively infected cells of HIV- and SIV-infected lymph nodes. Nat. Med. 1, 129-134.
24. Gil, L. et al. 2003 Contribution to characterization of oxidative stress in HIV/AIDS patients. Pharmacol. Res. 47, 217-224.
25. Goldsby, R. A., Kindt, T. J. & Osborne, B. A. 2000 Kuby immunology. New York: W. H. Freeman and Company.
26. Haase, A. T. et al. 1996 Quantitative image analysis of HIV-1 infection in lymphoid tissue. Science 274, 985-989.
27. Harari, A., Petitpierre, S., Vallelian, F. & Pantaleo, G. 2004 Skewed representation of functionally distinct populations of virus-specific CD4 T cells in HIV-1-infected subjects with progressive disease: changes after antiretroviral therapy. Blood 103, 966-972.
28. Hayflick, L. & Moorehead, P. 1961 The serial cultivation of human diploid cell strains. Exp. Cell Res. 25, 585-621.
29. Haynes, B. F. et al. 1999 Analysis of the adult thymus in reconstitution of T lymphocytes in HIV-1 infection. J. Clin. Invest. 103, 453-460.
30. Hazenberg, M. D., Stuart, J. W., Otto, S. A., Borleffs, J. C., Boucher, C. A., de Boer, R. J., Miedema, F. & Hamann, D. 2000 T-cell division in human immunodeficiency virus (HIV)-1 infection is mainly due to immune activation: a longitudinal analysis in patients before and during highly active antiretroviral therapy (HAART). Blood 95, 249-255.
31. Hazenberg, M. D., Otto, S. A., Hamann, D., Roos, M. T. L., Schuitemaker, H., de Boer, R. J. & Miedema, F. 2003 Depletion of naive CD4 T cells by CXCR4-using HIV-1 variants occurs mainly through increased T-cell death and activation. AIDS 17, 1419-1424.
32. Hazuda, D. J. et al. 2004 Integrase inhibitors and cellular immunity suppress retroviral replication in rhesus macaques. Science 305, 528-532.
33. Hellerstein, M. et al. 1999 Directly measured kinetics of circulating T lymphocytes in normal and HIV-1-infected humans. Nat. Med. 5, 83-89.
34. Ho, D. D., Neumann, A. U., Perelson, A. S., Chen, W., Leonard, J. M. & Markowitz, M. 1995 Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 373, 123-126.
35. Idilman, R., Colantoni, A., De Maria, N., Alkan, S., Nand, S. & Van Thiel, D. 2004 Lymphoproliferative disorders in chronic hepatitis C. J. Viral Hepat. 4, 302-309.
36. [beta] sequences. Science 254, 860-862.
37. Jin, X. et al. 1999 Dramatic rise in plasma viremia after CD8(+) T cell depletion in simian immunodeficiency virus-infected macaques. J. Exp. Med. 189, 991-998.
38. Kaufmann, G. R., Bloch, M., Finlayson, R., Zaunders, J., Smith, D. & Cooper, D. A. 2002 The extent of HIV-1-related immunodeficiency and age predict the long-term CD4 T lymphocyte response to potent antiretroviral therapy. AIDS 16, 359-367.
39. Klenerman, P., Phillips, R. E., Rinaldo, C. R., Wahl, L. M., Ogg, G., May, R. M., McMichael, A. J. & Nowak, M. A. 1996 Cytotoxic T lymphocytes and viral turnover in HIV type 1 infection. Proc. Natl Acad. Sci. USA 93, 15 323-15 328.
40. Marsham, E., Booth, C. & Potten, C. S. 2002 The intestinal epithelial stem cell. Bioessays 24, 91-98.
41. Mascola, J. R. 2003 Defining the protective antibody response for HIV-1. Curr. Mol. Med. 3, 209-216.
42. Meyaard, L., Otto, S. A., Jonker, R. R., Mijnuster, M. J., Keet, R. P. & Miedema, F. 1992 Programmed death of T cells in HIV-T infection. Science 257, 217-219.
43. Miedema, F. et al. 1994 Changing virus-host interactions in the course of HIV-1 infection. Immunol. Rev. 140, 35-72.
44. Mohri, H., Bonheffer, S., Monard, S., Perelson, A. S. & Ho, D. D. 1998 Rapid turnover of T lymphocytes in SPV-infected rhesus macaques. Science 279, 1223-1227.
45. Mohri, H. et al. 2001 Increased turnover of T lymphocytes in HIV-1 infection and its reduction by antiretroviral therapy. J. Exp. Med. 194, 1277-1287.
46. Moses, A., Nelson, J., Babgy, J. & G. C. 1998 The influence of human immunodeficiency virus-1 on hematopoiesis. Blood 91, 1479-1495.
47. Muller, H. J. 1964 The relation of recombination to mutational advance. Mutat. Res. 1, 2-9.
48. Murray, H. W., Rubin, B. Y., Masur, H. & Roberts, R. B. 1984 Impaired production of lymphokines and immune (gamma) interferon in the acquired immunodeficiency syndrome. N. Engl. J. Med. 310, 883-889.
49. Nowak, M. A., Anderson, R. M., Mclean, A. R., Wolfs, T. F., Goudsmit, J. & May, R. M. 1991 Antigenic diversity thresholds and the development of AIDS. Science 254, 963-969.
50. O'Brien, S. J. & Moore, J. P. 2000 The effect of genetic variation in chemokines and their receptors on HIV transmission and progression to AIDS. Immunol. Rev. 177, 99-111.
51. Paganin, C., Monos, D. S., Marshall, J. D., Frank, I. & Trinchieri, G. 1997 Frequency and cytokine profile of HPRT mutant T cells in HIV-infected and healthy donors: implications for T cell proliferation in HPV diseases. J. Clin. Invest. 99, 663-668.
52. +T cells from HIV-discordant monozygotic twins. J. Exp. Med. 185, 1381-1386.
53. Pantaleo, G., Graziosi, C. & Fauci, A. S. 1993 The immunopathogenesis of human immunodeficiency virus infection. N. Engl. J. Med. 328, 327-335.
54. Perelson, A. S., Neumann, A. U., Markowitz, M., Leonard, J. M. & Ho, D. D. 1996 HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time. Science 271, 1582-1586.
55. Qin, X. F., An, D. S., Chen, I. S. Y. & Baltimore, D. 2003 Inhibiting HIV-1 infection in human T cells by lentiviral-mediated delivery of small interfering RNA against CCR5. Proc. Natl Acad. Sci. USA 100, 183-188.
56. Ramratnam, B. et al. 1999 Rapid production and clearance of HIV-1 and hepatitis C virus assessed by large volume plasma apheresis. Lancet 354, 1782-1785.
57. +T cells depleted? Proc. Natl Acad. Sci. USA 99, 15 572-15 577.
58. Rosenberg, E. S. et al. 2000 Immune control of HIV-1 after early treatment of acute infection. Nature 407, 523-526.
59. Sabin, C. A., Devereux, H., Phillips, A. N., Hill, A., Janossy, G., Lee, C. A. & Loveday, C. 2000 Course of viral load throughout HIV-1 infection. J. Acquir. Immune Defic. Syndr. 23, 172-177.
60. + lymphocytes. Science 283, 857-860.
61. Schnittman, S. M., Psallidopoulos, M. C., Lane, H. C., Thompson, L., Baseler, M., Massari, F., Fox, C. H., Salzman, N. P. & Fauci, A. S. 1989 The reservoir for HIV-1 in human peripheral blood is a T cell that maintains expression of CD4. Proc. Natl Acad. Sci. USA 245, 305-308.
62. Shochat, E., Stemmer, S. M. & Segel, L. 2002 Human haematopoiesis in steady state and following intense pertubations. Bull. Math. Biol. 64, 861-886.
63. Stevenson, M. 2003 HIV-1 pathogenesis. Nat. Med. 9, 853-860.
64. Sugaya, M., Lore, K., Koup, R. A., Douek, D. C. & Blauvelt, A. 2004 HIV-infected langerhans cells preferentially transmit virus to proliferating autologous CD4+ memory T cells located within langerhans cell-T cell clusters. J. Immunol. 172, 2219-2224.
65. Tailor, P. B., Saikia, T. K., Advani, S. H. & Mukhopadhyaya, R. 2004 Activation of HHV-6 in lymphoproliferative disorders: a polymerase chain reaction-based study. Ann. N. Y Acad. Sci. 1022, 282-285.
66. Trkola, A. et al. 2004 Humoral immunity to HIV-1: kinetics of antibody responses in chronic infection reflects capacity of immune system to improve viral set point. Blood 104, 1784-1792.
67. Valdez, H. et al. 2002 Limited immune restoration after 3 years suppression of HIV-1 replication in patients with moderately advanced disease. AIDS 16, 1859-1866.
68. Wabl, M., Jack, H. M., Meyer, J., Beck-Engeser, G., von Borstel, R. C. & Steinberg, C. M. 1987 Measurements of mutation rates in B lymphocytes. Immunol. Rev. 96, 91-107.
69. + T-cell regeneration HIV-infected adults. Nat. Med. 4, 852-856.
70. Wei, X. et al. 1995 Viral dynamics in human immunondeficiency virus type 1 infection. Nature 373, 117-122.